7,400
Participants
Start Date
February 28, 2013
Primary Completion Date
January 31, 2030
Study Completion Date
January 31, 2030
Concomitant Open Heart Surgical Ablation Procedures
AtriCure's Concomitant Open Heart Surgical Ablation Devices used for the treatment of Atrial Fibrillation.
Hybrid (Convergent) Ablation Procedures
AtriCure's Hybrid (Convergent) Ablation Devices used for the treatment of Atrial Fibrillation.
AtriCure Hybrid Totally Thoracoscopic Ablation Procedures
AtriCure's Hybrid Totally Thoracoscopic Surgical Ablation Devices used for the treatment of Atrial Fibrillation.
AtriCure LAA Exclusion Procedures
AtriCure's LAA Exclusion Devices used to exclude the Left Atrial Appendage for the treatment of Atrial Fibrillation.
RECRUITING
Maimonides Health Heart & Vascular Institute, Brooklyn
RECRUITING
MedStar Washington Hospital, Washington D.C.
RECRUITING
Atrium Health Wake Forest Baptist, Winston-Salem
RECRUITING
University of Florida, Gainesville
RECRUITING
Orlando Health Heart & Vascular Institute, Orlando
RECRUITING
Delray Medical Center, Delray Beach
RECRUITING
St. Joseph's Hospital (BayCare), Tampa
RECRUITING
Huntsville Hospital, Huntsville
RECRUITING
Centennial Medical Center, Nashville
RECRUITING
Jackson Madison County General Hospital, Jackson
RECRUITING
Norton Heart & Vascular Institute, Louisville
RECRUITING
UH Cleveland Harrington Heart & Vascular Institute, Cleveland
RECRUITING
Franciscan Health, Indianapolis
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Corewell Health, Grand Rapids
RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
Kansas City Heart Rhythm Institute, Overland Park
RECRUITING
CHI St. Vincent Heart Institute, Little Rock
RECRUITING
Michael E. DeBakey VAMC - Houston, Houston
RECRUITING
Loma Linda University Medical Center, Loma Linda
RECRUITING
Adventist Heart Institute (St. Helena Hospital), St. Helena
RECRUITING
Nova Scotia Health Authority, Halifax
RECRUITING
Waterloo Regional Health Network, Kitchener
Lead Sponsor
AtriCure, Inc.
INDUSTRY